About

Why we're building this.

Cancer is the leading cause of death in dogs over ten. The science to do better — much better — quietly became possible over the last few years. The question isn't whether modern oncology can help your dog. It's whether anyone has bothered to put the pieces together where you can reach them.

The thesis

Three things shifted at roughly the same time. (1) The open-source biomedical model stack — protein structure, neoantigen prediction, drug-mutation matching, RNA-seq — became good enough and cheap enough that a small team can run a precision-oncology workup on any patient. (2) USDA-CVB opened a conditional-licensure path for autologous therapeutic biologics, which means novel personalized treatments can reach real patients without waiting decades. (3) Comparative oncology has finally been taken seriously: dogs get the same cancers humans do, and what we learn in dogs accelerates human oncology.

Why a unified portal

Today, even when all the right pieces exist, they live in different places. Genomics is at one vendor. Imaging is at another. The biopsy report is a PDF in your email. The chemo schedule is in your vet's practice management system. The symptom log, if it exists at all, is on a Post-it on your fridge. Owners stitch all this together at the worst possible time. We don't think they should have to.

Our role with your dog

SciRouter Oncology is decision-support, not a diagnostic device. The licensed veterinarian on your dog's case retains full clinical authority and prescribing responsibility. What we add is the common workspace: the same record visible to you, your GP, and your specialty oncologist, with the open-source biomedical model stack running underneath when it's useful.

Our role with research

If — and only if — you opt in, your dog's de-identified record helps researchers and vets find treatments faster. The data flywheel is owner-controlled, owner-revocable, and audit-logged. We do not sell records to pharma; we publish from the cohort and collaborate with academic medical centers on comparative oncology trials.

Who we are

SciRouter Oncology is a vertical of SciRouter, the unified API for scientific computing. We were already routing the open-source biomedical model stack for drug-discovery customers when Rosie's story in March 2026 made it clear the same stack should be available, in workspace form, to every family with a dog facing cancer.

Where we go next

Phase 0: the public information surface and signup, live now. Phase 1: owner + vet portals with document parsing and cohort comparator. Phase 2: genomics ingestion from any lab. Phase 3: personalized mRNA neoantigen vaccine pilot under university partnership and USDA-CVB conditional licensure. Phase 4: comparative oncology clinical trials feeding human Phase I/II target selection. The strategy is the science, and the workspace is the wedge that gets us there.